Official UK procurement notice
Provisions of DNA Maxwell Kits
Procurement agent: Cardiff and Vale University Health Board
What is being bought
Published requirement descriptionTo ensure uninterrupted availability, these kits are managed through the Helix cabinet reordering system—an automated inventory solution that monitors stock levels and facilitates real-time replenishment. This system helps prevent delays or disruptions to clinical operations.The Promega kits are uniquely validated for use with the Maxwell RSC instruments currently deployed across AWMGS laboratories. This validation guarantees that the kits meet the rigorous performance and quality standards required for clinical diagnostics. Due to this specific compatibility, no alternative supplier can provide products that meet the same technical and regulatory specifications.This exclusivity forms the basis of the procurement decision, ensuring continuity of service and compliance with clinical standards. By continuing to source these validated kits, AWMGS safeguards the accuracy, reliability, and regulatory compliance of its genomic testing services—supporting timely and effective patient care.
The lotProcurement structure
single lot · no lot value publishedLot #1Awarded
Procedure terms & legal framework
From the official record- Procedure method
- Direct award
- Legal basis
- UKPGA · 2023/54 Procurement Act 2023
- Notice status
- Awarded without competition
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Direct award (no call for competition)
- GPA / WTO covered
- Unspecified in notice
- Recurring procurement
- Unspecified in notice
- First published
- 10 Nov 2025, 15:32 GMT
- Last source update
- 1 Dec 2025, 14:49 GMT
- Authority reference
CAV-DIR (25-26) 134- FTS notice number
2025/S 000-078544- Latest notice
- Contract details notice (UK7)
- Delivery area
- Official registry OCID
ocds-h6vhtk-05ddf2Find a Tender
- Why no open competition
- Single Suppliers Technical Reasons
- Published justification
The Promega Maxwell RSC kits and Casework Extraction Kits are specifically validated for use with the Maxwell RSC instruments currently deployed across AWMGS laboratories. This validation ensures: Compatibility with existing equipment and workflows. Compliance with stringent clinical diagnostic standards. Reliable performance across a wide range of clinical sample types. These kits are integral to the laboratory’s ability to deliver accurate and timely genomic testing. Substituting them with non-validated alternatives would: Risk compromising test accuracy and reliability. Require revalidation, disrupting service delivery and incurring additional costs. Potentially breach regulatory compliance for clinical diagnostics. Unique Work of Art The Promega kits represent a bespoke solution tailored to the Maxwell RSC platform. Their unique formulation and design: Cannot be replicated by other suppliers. Are not available through generic or alternative sources. Form an essential part of a closed-loop system that includes automated inventory management via the Helix cabinet reordering system. This exclusivity ensures continuity of service, minimises operational risk, and supports the delivery of high-quality patient care.
- Risks
The procurement of Promega Maxwell RSC kits for AWMGS is governed by contract terms that ensure validated compatibility with existing laboratory instruments, regulatory compliance, and uninterrupted supply through the Helix cabinet system. Key provisions include fixed pricing, defined delivery schedules, and performance standards aligned with clinical diagnostics. Risks associated with single supplier dependency, supply chain disruption, and regulatory changes are mitigated through automated inventory monitoring, contingency planning, and regular supplier performance reviews, ensuring continuity and reliability in patient testing services.
How it was run
Official notice- Submission deadline
- —
Timeline
20 Nov 2025 → 1 Dec 2025 · 2 dates- Standstill ends336 days ago20 Nov 2025, 23:59 GMT
- Notice published325 days ago1 Dec 2025, 14:49 GMT
Notice history
4 events · 3 releases on Find a Tender · since 10 Nov 2025- Transparency notice published10 Nov 2025, 15:32 GMTUK5
- Contract award notice published11 Nov 2025, 08:14 GMTUK6
- Contract signature expected24 Nov 2025, 23:59 GMTscheduled
- Contract details notice published1 Dec 2025, 14:49 GMTUK7
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast| Awarded to | Value | Date | Status |
|---|---|---|---|
| Promega UK LtdProvision of DNA Maxwell Kits1 Jan 2026 – 31 Dec 2028 | £401,048 | 3 Nov 2025 | Awarded |
Contracts
Provisions of DNA Maxwell Kits · Promega UK Ltd
- Signed
- 24 Nov 2025
- Value
- £401,048
- Period
- 1 Jan 2026 – 31 Dec 2028
- Status
- active
Contracting authority & participating public bodies
2 public bodies on the noticeClients of the procurement agent
- NHS Wales Shared Services Partnership (hosted by Velindre University NHS Trust) role in NWSSPProcuring entityThe NHS Wales Shared Services Partnership (NWSSP) plays a vital role in supporting NHS Wales by delivering a wide range of professional, technical, and administrative services. It is hosted by Velindre University NHS Trust, which means Velindre provides the governance and infrastructure to support NWSSP’s operations, but NWSSP itself serves all NHS organisations across Wales.
Bidders & participating suppliers
1 commercial party on the notice- Promega UK LTDAwarded supplier
Official documents & specifications (4)
Official links; attachments are not copiedTender pack and attachments
Notices published for this procedure
- Contract details notice Contract details notice on Find a Tender
- Contract award notice Contract award notice on Find a Tender
- Transparency notice Transparency notice on Find a Tender